Day: April 3, 2023

Cargotec Corporation, managers’ transactions: Byström, Leif

Written by Customer Service on April 3, 2023. Posted in Public Companies.

CARGOTEC CORPORATION, MANAGERS’ TRANSACTIONS, 3 APRIL 2023 AT 4:00 PM (EEST) Cargotec Corporation, managers’ transactions: Byström, Leif ____________________________________________ Person subject to the notification requirementName: Byström, LeifPosition: Other senior managerIssuer: Cargotec CorporationLEI: 5493002B0GOVF42KWX33 Notification type: INITIAL NOTIFICATIONReference number: 5493002B0GOVF42KWX33_20230331112027_90____________________________________________ Transaction date: 2023-03-31Venue not applicableInstrument type: SHAREISIN: FI0009013429Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 1500 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 1500 Volume weighted average price: 0.00 EUR For further information, please contact: Martti Henttunen, Senior Manager,...

PetMeds® Completes Acquisition of PetCareRx

Written by Customer Service on April 3, 2023. Posted in Mergers And Acquisitions.

DELRAY BEACH, Fla., April 03, 2023 (GLOBE NEWSWIRE) — PetMed Express, Inc. (“PetMeds®”) (NASDAQ: PETS), Your Trusted Pet Health Expert™ completed its previously announced acquisition of PetCareRx, a leading supplier of pet medications, food, and supplies, for total consideration of approximately $36 million in an all-cash transaction. The acquisition will expand PetMeds’ overall addressable market from pet medication to a broader healthcare category leader. PetCareRx adds approximately 10,000 incremental food, diet and wellness products to the PetMeds current product offering. PetMeds believes it can expand its growth through a broader product catalog and differentiated services. “We are extremely excited to welcome the PetCareRx team into the PetMedsPack,” said Matt Hulett, CEO and President of PetMeds. “PetCareRx is a...

Global Fuel Cell Market Size Worth USD 36.41 Billion, Globally, by 2029 at a CAGR of 29.7%

Written by Customer Service on April 3, 2023. Posted in Mergers And Acquisitions.

The global fuel cell market size is projected to reach USD 36.41 billion in 2029, at compound annual growth rate (CAGR) of 29.7% during the forecast period. The global fuel cell industry was valued at USD 4.58 billion in 2021. Pune, India, April 03, 2023 (GLOBE NEWSWIRE) — The global fuel cell market size was gauged at USD 4.58 billion in 2021. The market is projected to grow from USD 5.90 billion in 2022 to USD 36.41 billion by 2029, showcasing a CAGR of 29.7% during the 2022-2029 period. Announcement of regulatory policies favoring fuel cell deployment in several countries, surging demand for clean energy sources, and growing investments in research & development are the factors driving market growth. This information is provided by Fortune Business Insights, in its report titled, “Fuel Cell Market, 2022-2029.” Key Industry...

Global Intelligent Vending Machine Market Size Worth USD 22.0 Billion, Globally, by 2029 at a CAGR of 16.7%

Written by Customer Service on April 3, 2023. Posted in Mergers And Acquisitions.

The global grinding machines market size is projected to reach USD 22.0 billion in 2029, at compound annual growth rate (CAGR) of 16.7% during the forecast period. The global intelligent vending machine industry was valued at USD 6.51 billion in 2021. Pune, India, April 03, 2023 (GLOBE NEWSWIRE) — The global intelligent vending machine market size was valued at USD 6.51 billion in 2021 and USD 7.44 billion in 2022. The market is expected to reach USD 22.0 billion by 2029 with a CAGR of 16.7% during the forecast period. Unique user experience created using such machines is expected to propel the market course in a growing direction. Integration of the Internet of Things (IoT) and technological advancements are expected to facilitate market development for intelligent vending machines. Fortune Business Insights™ shares this...

US Blood Glucose Monitoring System Market Size Worth USD 12.94 billion by 2030, exhibiting 9.6% CAGR

Written by Customer Service on April 3, 2023. Posted in Mergers And Acquisitions.

As per the report by Fortune Business Insights, the global US Blood Glucose Monitoring System Market size is projected to reach USD 12.94 billion in 2030, at a CAGR of 9.6% during the forecast period, 2023-2030 Pune, India, April 03, 2023 (GLOBE NEWSWIRE) — The global US Blood Glucose Monitoring System Market was estimated at USD 6.26 billion in 2022. The market valuation is slated to rise from USD 6.82 billion in 2023 to USD 12.94 billion by 2030 at a 9.6% CAGR during the forecast period. Medical equipment called a blood glucose monitoring system is used to keep track of people’s blood glucose levels, particularly those with type 1 and type 2 diabetes. These tools can quickly and accurately measure blood glucose levels, allowing medical decisions to be based on the blood sugar level. Industry Development: February 2022 Senseonics...

MCI Onehealth Reports Fiscal 2022 Financial Results and Announces Review of Strategic Alternatives

Written by Customer Service on April 3, 2023. Posted in Earnings Releases And Operating Results.

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 03, 2023 (GLOBE NEWSWIRE) — MCI Onehealth Technologies Inc. (“MCI” or the “Company”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, has released its financial results for the financial year ended December 31, 2022 and announced that it is engaged in a review of strategic alternatives available to the Company. A summary of MCI’s financial and operational results is set out below, and more detailed information is contained in the financial statements and related management discussion and analysis, which are available on MCI’s SEDAR page at www.sedar.com. Financial measures described as “Adjusted” in this news release are non-IFRS financial measures and may not...

Eloxx Pharmaceuticals Reports Fourth Quarter 2022 Financial and Operating Results and Provides Business Update

Written by Customer Service on April 3, 2023. Posted in Earnings Releases And Operating Results.

Three patients now dosed in Phase 2 clinical study evaluating ELX-02 for the treatment of Alport syndrome; encouraging initial reduction in proteinuria has been observed in one patient to date Investigational New Drug (IND) application for ZKN-013 filed for treatment of recessive dystrophic epidermolysis bullosa (RDEB) WATERTOWN, Mass., April 03, 2023 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today reported its financial results for the three months ended December 31, 2022 and provided a business update. “With topline data expected for ELX-02 in Alport syndrome in the first half of 2023, we believe we are approaching a significant milestone for the company, to advance into our first Phase 3 study, with the potential to create significant...

Vaccinex Reports 2022 Financial Results and Provides Corporate Update of Continued Progress in Neurology and Oncology Clinical Programs

Written by Customer Service on April 3, 2023. Posted in Earnings Releases And Operating Results.

Expect to complete patient enrollment in the randomized Phase 1/2a SIGNAL-AD Alzheimer’s study in April 2023 with topline data anticipated mid-2024 Completed enrollment of 36 patients required for a pre-planned interim analysis of KEYNOTE B84 phase 1b/2 study in Head and Neck Squamous Cell Carcinoma ROCHESTER, N.Y., April 03, 2023 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D today announced financial results for the fourth quarter ended December 31, 2022 and provided a corporate update on key programs. In 2022 and continuing in Q1 2023, Vaccinex has made important clinical progress in its major neurology and oncology programs. This month the company will complete enrollment...

One Duck Creek Summit to celebrate its efforts across connection, culture and community

Written by Customer Service on April 3, 2023. Posted in Public Companies.

Boston, April 03, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, will host the One Duck Creek Summit, April 4-6, 2023, in Boston, Massachusetts, bringing leaders together to focus on connection, culture and community. The global attendees are credited for leading the various critical initiatives and programs that make Duck Creek a culture champion in the insurance and technology industries. The diverse collection of people in attendance will spend their time together reflecting on past initiatives and planning future endeavors and setting goals to continue building upon the award-winning culture at Duck Creek. The One Duck Creek Summit will be kicked off by CEO Mike Jackowski, who will emphasize the significance of...

Clever Leaves to Present at Sequire Cannabis & Psychedelics Conference on April 5, 2023 at 2:30 p.m. ET

Written by Customer Service on April 3, 2023. Posted in Public Companies.

TOCANCIPÁ, Colombia, April 03, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today that it will be presenting virtually at the upcoming Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, at 2:30 p.m. Eastern time. Event: Clever Leaves Presentation at the Sequire Cannabis & Psychedelics ConferenceDate: Wednesday, April 5, 2023Time: 2:30 p.m. Eastern time Register to watch here: https://cannabis.sequireevents.com/ To receive additional information, please contact your Sequire representative or the Company’s investor relations team at CLVR@gatewayir.com. Summary of Sequire Cannabis & Psychedelics Conference The cannabis and psychedelic...

Day: April 3, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice